These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29513300)

  • 1. Heading Toward the Elimination of Hepatitis C Virus.
    Kershenobich D; Torre-Delgadillo A; Aguilar-Valenzuela LM
    Rev Invest Clin; 2018; 70(1):29-31. PubMed ID: 29513300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
    Kim KA; Chung W; Choi HY; Ki M; Jang ES; Jeong SH
    Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates on HCV disease burden worldwide - filling the gaps.
    Wedemeyer H; Dore GJ; Ward JW
    J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicted effects of treatment for HCV infection vary among European countries.
    Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P
    Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular epidemiology of chronic hepatitis C (HCV) virus].
    Nitkiewicz J
    Przegl Epidemiol; 2004; 58(3):413-21. PubMed ID: 15730005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for chronic hepatitis C virus.
    Shiffman ML
    Liver Int; 2016 Jan; 36 Suppl 1():62-6. PubMed ID: 26725899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on hepatitis C: epidemiology, treatment and resistance to antiviral therapies.
    Ness E; Kowdley KV
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):145-58. PubMed ID: 25990619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C-A clinical review.
    Wang LS; D'Souza LS; Jacobson IM
    J Med Virol; 2016 Nov; 88(11):1844-55. PubMed ID: 27097298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals.
    Akuta N; Kobayashi M; Suzuki F; Sezaki H; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
    Oncology; 2016; 91(6):341-347. PubMed ID: 27694754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting.
    Chirino-Sprung RA; Dehesa M; Wolpert E; Corona-Lau C; García-Juarez I; Sánchez-Ávila JF; Moctezuma-Velázquez C; Kershenobich D
    Rev Invest Clin; 2016; 68(4):203-12. PubMed ID: 27623039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C genotype 3 disease.
    Kattakuzhy S; Levy R; Rosenthal E; Tang L; Wilson E; Kottilil S
    Hepatol Int; 2016 Nov; 10(6):861-870. PubMed ID: 27328848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.
    Durham DP; Skrip LA; Bruce RD; Vilarinho S; Elbasha EH; Galvani AP; Townsend JP
    Clin Infect Dis; 2016 Feb; 62(3):298-304. PubMed ID: 26628566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hepatitis C virus outside the liver: Evidence from Asia.
    Younossi ZM; Tanaka A; Eguchi Y; Lim YS; Yu ML; Kawada N; Dan YY; Brooks-Rooney C; Negro F; Mondelli MU
    Liver Int; 2017 Feb; 37(2):159-172. PubMed ID: 27748564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of hepatitis C cure with antivirals: why test and treat?
    Lledó G; Benítez-Gutiérrez L; Arias A; Requena S; Cuervas-Mons V; de Mendoza C
    Future Microbiol; 2019 Mar; 14():425-435. PubMed ID: 30900911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urgency to treat patients with chronic hepatitis C in Asia.
    Kao JH; Ahn SH; Chien RN; Cho M; Chuang WL; Jeong SH; Liu CH; Paik SW
    J Gastroenterol Hepatol; 2017 May; 32(5):966-974. PubMed ID: 28005275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis C virus.
    Shiffman ML
    Oncology; 2010 Jul; 78 Suppl 1():11-6. PubMed ID: 20616578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths.
    Sievert W; Razavi H; Thompson A; Zekry A; Dore GJ; Roberts SK
    Med J Aust; 2015 May; 202(9):479. PubMed ID: 25971570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.